Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing
Contributions to Nephrology · 2023
DOI: 10.1159/000527774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Contributions to Nephrology, 2023. Verfasst von Gerd Klinkmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University of Rostock, Rostock, Germany. Hauptthemen laut MEDLINE: Shock, Septic, Hemoperfusion, Sepsis. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University of Rostock, Rostock, Germany.
- Fraunhofer Institute for Cell Therapy and Immunology, Department of Extracorporeal Therapy Systems, Rostock, Germany.
- Department of Medicine, Division of Nephrology, Medical Faculty, University of Rostock, Rostock, Germany.
Zitieren
APA
Klinkmann, G., Koball, S., Reuter, D. A., & Mitzner, S. (2023). Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing. Contributions to Nephrology. https://doi.org/10.1159/000527774
Vancouver
Klinkmann G, Koball S, Reuter DA, Mitzner S. Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing. Contributions to Nephrology. 2023. doi:10.1159/000527774
BibTeX
@article{Klinkmann2023,
author = {Klinkmann, Gerd and Koball, Sebastian and Reuter, Daniel A and Mitzner, Steffen},
title = {Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing},
journal = {Contributions to Nephrology},
year = {2023},
doi = {10.1159/000527774}
}
EUVIMED